Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Janssen Pharmaceuticals Inc.

www.janssenpharmaceuticalsinc.com

Latest From Janssen Pharmaceuticals Inc.

Pediatric Data Planning Should Start While Adult Drug Development Is In Its Infancy

Innovative trial designs and biostatistics can make pediatric drug development more efficient, but strategies like extrapolating adult data using bridging biomarkers or Bayesian analyses have complex data requirements that demand coordination and forethought.

Pediatrics Clinical Trials

Nuvaxovid COVID-19 Vaccine Wins EU Approval

Initial doses of Novavax’s vaccine are expected to arrive in Europe in January.

Europe Approvals

BeiGene Switches To Combo Therapy Approach For Brukinsa

BeiGene exec reveals Chinese firm's changing development strategy around key asset as further clinical results emerge.

China Clinical Trials

The Evolving Door? What Having A ‘Big Data’ Commissioner Might Mean For US FDA

Robert Califf’s nomination to return as FDA commissioner will raise protests about a ‘revolving door’ pathway between industry and agency. But, in this case, it may be more apt to talk about how Califf’s time outside FDA led to evolving views on the role of big data in drug regulation.

FDA Leadership
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register